IL‐1β neutralization significantly reduced IL‐17A and IL‐22 expression in bladder ILC3s during UTI (Figure 6D), demonstrating the role of IL‐1β in activating ILC3s in vivo. The gene discussed is IL22; the disease is bacterial urinary tract infection.